Relationship between Illness Perception and Depressive Symptoms among Type 2 Diabetes Mellitus Patients in China: A Mediating Role of Coping Style

Abstract

Objective. The aims of the present study were to investigate the prevalence of depressive symptoms among type 2 diabetes mellitus (T2DM) patients in China and to explore how coping style influences the relationship between illness perception and depressive symptoms. Methods. Nine hundred and thirty-nine T2DM patients were recruited from a grade 3 Class A hospital in Harbin, China, and asked to complete a demographic questionnaire as well as the Self-rating Depression Scale (SDS), Brief Illness Perception Questionnaire-Revised (IPQ-R), and Medical Coping Modes Questionnaire (MCMQ). Hierarchical linear regression analysis and the bootstrap method were preformed to examine if coping style influenced the relationship between illness perception and depression. Results. The majority of patients (73.59%) exhibited depressive symptoms, including 37.27% with moderate and 6.71% with severe depressive symptoms. Depressive symptoms were more frequent in patients with complications ( P < 0.05 ). A resignation coping style partially mediated the influence of illness perception on depressive symptoms. Conclusions. Interventions to improve coping style may reduce the prevalence or severity of depressive symptoms among T2DM patients, potentially enhancing treatment adherence and clinical outcome.

Relationship Between Social Capital and Depressive Symptoms Among Type 2 Diabetes Mellitus Patients in Northwest China: A Mediating Role of Sleep Quality

“…In this study, our finding of 24.8% T2DM patients with depressive symptoms (CES-D score ≥ 16) is lower than the prevalence of depressive symptoms among Japanese (29.9%) ( 31 ) and Nepalese (44.1%) ( 32 ) T2DM patients and higher than in northeast China (8.76%) ( 33 ). The reasons for this phenomenon may be owing to different samples, survey regions, and measurement instruments or clinical factors, such as disease duration and severity ( 2 ). The incidence of depression is higher in diabetic patients than in the general population ( 34 ); this may be due to poor sleep quality ( 35 ), long-term medication, or several complications ( 36 ).…”

“…As one of the most common chronic non-communicable diseases in the world, diabetes mellitus has become an increasingly serious global health problem ( 1 ). More than 90% of diabetes mellitus cases are classified as type 2 diabetes mellitus (T2DM) ( 2 ). China has the largest diabetes patients in the world; the number of diabetes patients in China reached 114.4 million in 2017 ( 3 ).…”

Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross‐sectional study

“…Positive illness perception can improve patients' psychological state, correct their unreasonable behaviour habits and cognitive deviations, improve their level of self‐management and ultimately improve the quality of life (Fennessy et al, 2013). In contrast, adverse illness perception will reduce the self‐perception of health, increase adverse emotional reactions caused by disease, aggravate anxiety and negative wrong psychology, making it difficult for patients to build up confidence and deal with treatment plans actively (Huang et al, 2020; Li et al, 2020; Yildirim & Baykal, 2020). It is not conducive to the self‐management of the disease and results in poor prognosis and poor quality of life.…”

Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine

“…Based on World Health Organization (WHO) estimation, the global prevalence of this disease is rising annually, up to about 450 million in 2019 [ 5 ]. In China, the number of DM patients is about 116.4 million in 2019, which is the largest such population worldwide [ 6 ]. There are two major types of DM: Type 1 and type 2 diabetes; the later accounts for 90–95% of those with DM [ 7 ].…”

“…There are two major types of DM: Type 1 and type 2 diabetes; the later accounts for 90–95% of those with DM [ 7 ]. It is estimated that there are a total of 1.6 million DM-related deaths in 2016 [ 6 ], and the number is increased to 4 million in 2019 [ 8 ].…”